Electrification In Life Sciences: More Than A Power Upgrade

Electrification in life sciences is emerging as a strategic imperative beyond mere carbon reduction. New research reveals it ...
TMCnet

Prezent Vivo Appoints Lalit Mahapatra as CFO to Scale the Future of Life Sciences Communication

Lalit Mahapatra joins Prezent Vivo as CFO with more than 25 years of global finance, M&A, and Life Sciences experience as the company scales its AI-powered communication platform ...

EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financing

EQT Life Sciences is investing USD 17.5 million in Vaderis Therapeutics as part of the Swiss company's USD 152 million Series B financing ...
STAT

Gilead to buy cancer biotech Tubulis for more than $3 billion

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. In a move that will grow its ...
Rutland Herald

Carelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences Researchers

Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, today announced a strategic partnership that gives life sciences researchers and data ...
Scientific Computing World

Transforming life sciences research with semantic knowledge technology

Life sciences organisations generate data at extraordinary speed, but insight remains slow. Semantic knowledge graphs and ontologies address this by providing context and structur ...

Wave Life Sciences: An Fairly Valued RNA Opportunity

Wave Life Sciences (WVE) stock analysis: low valuation (2.45x cash, no debt) vs. RNA therapy competition; key upside tied to WVE-N531 results. See more here.